
Henry Schein (HSIC) Stock Forecast & Price Target
Henry Schein (HSIC) Analyst Ratings
Bulls say
Henry Schein is well-positioned for growth with its strong presence in the dental and medical industries, strategic focus on office-based healthcare, and plans for mergers and acquisitions. Despite potential challenges, such as low reimbursement rates, the company has a solid financial outlook and remains positive about its future. Risks such as cybersecurity attacks and supply chain disruptions should be monitored, but the company has a target price of $97 and a strong potential for international expansion in addition to their solid US presence.
Bears say
Henry Schein is facing numerous headwinds from a slower global economic environment, the potential impact of the ongoing war in Iran, and increasing competition within the healthcare distribution industry. Additionally, the company's lower projected revenue growth and EBITDA margin compared to its sub-sector peers indicate potential struggles in maintaining its market leadership position. Its significant debt load also poses a risk to its ability to invest in future growth opportunities.
This aggregate rating is based on analysts' research of Henry Schein and is not a guaranteed prediction by Public.com or investment advice.
Henry Schein (HSIC) Analyst Forecast & Price Prediction
Start investing in Henry Schein (HSIC)
Order type
Buy in
Order amount
Est. shares
0 shares